Jane Street’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-76,704
Closed -$947K 11077
2024
Q4
$947K Sell
76,704
-41,509
-35% -$475K ﹤0.01% 5496
2024
Q3
$1.35M Sell
118,213
-82,136
-41% -$824K ﹤0.01% 5276
2024
Q2
$1.43M Sell
200,349
-305,525
-60% -$2.34M ﹤0.01% 5097
2024
Q1
$3.39M Buy
505,874
+430,690
+573% +$2.96M ﹤0.01% 3209
2023
Q4
$489K Buy
75,184
+37,741
+101% +$243K ﹤0.01% 6789
2023
Q3
$353K Buy
37,443
+5,652
+18% +$68K ﹤0.01% 6812
2023
Q2
$444K Sell
31,791
-98,701
-76% -$1.68M ﹤0.01% 6494
2023
Q1
$2.45M Buy
+130,492
New +$2.14M ﹤0.01% 3475
2022
Q4
Sell
-18,993
Closed -$363K 10347
2022
Q3
$363K Sell
18,993
-4,277
-18% -$77.9K ﹤0.01% 7267
2022
Q2
$355K Buy
+23,270
New +$344K ﹤0.01% 7327
2021
Q4
Sell
-26,077
Closed -$562K 10952
2021
Q3
$562K Sell
26,077
-14,179
-35% -$342K ﹤0.01% 7068
2021
Q2
$1.03M Buy
40,256
+17,316
+75% +$370K ﹤0.01% 5768
2021
Q1
$418K Buy
22,940
+11,645
+103% +$193K ﹤0.01% 7113
2020
Q4
$130K Buy
+11,295
New +$103K ﹤0.01% 7123
2019
Q3
Sell
-23,392
Closed -$131K 5898
2019
Q2
$131K Buy
+23,392
New +$96.4K ﹤0.01% 4802
2019
Q1
Sell
-19,944
Closed -$82K 5773
2018
Q4
$82K Buy
+19,944
New +$104K ﹤0.01% 4658
2015
Q3
Sell
-1,919
Closed -$18K 4266
2015
Q2
$18K Buy
1,919
+138
+8% +$1.33K ﹤0.01% 3559
2015
Q1
$17K Buy
+1,781
New +$17.1K ﹤0.01% 3054
2013
Q4
Sell
-2,070
Closed -$20K 2985
2013
Q3
$20K Sell
2,070
-11,041
-84% -$110K ﹤0.01% 2646
2013
Q2
$118K Buy
+13,111
New +$137K ﹤0.01% 2401

Other funds holding CDMO

Jane Street's CDMO Position: Q1 2025 in Review

Jane Street sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 76,704 shares — an estimated $947K sold.

Jane Street first reported a position in CDMO in Q2 2013 and held it in 20 quarters. The position peaked at $3.39M in Q1 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Jane Street reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Jane Street sold 76,704 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $947K.
  • Jane Street first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 20 quarters.
  • Jane Street's Avid Bioservices, Inc. Common Stock position peaked at $3.39M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.